missing translation for 'onlineSavingsMsg'
Learn More
Learn More
T-47D (human breast duct carinoma) Nuclear extract lysate, Non-denatured; Abnova
Marca: Abnova L006V4.50ug
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Western Blotting, Immunoprecipitation
Especificaciones
| Immunoprecipitation, Western Blot | |
| Nuclear extract cell lysate (non-denatured) | |
| Nuclear extract was prepared by using a modified protocol of Dignam et al. Cells were Harvested and homogenized in Buffer A, and then centrifugated at 25,000 g for 20 minutes to remove cytoplasm and pellet the nuclei. The pellet was re-suspended in Buffer C, and then the suspensions were centrifuged to collect nuclear extract. The supernatant was dialyzed against Buffer D. The dialysate was then centrifuged, divided into aliquots, and stored at -80°C. The protein concentration was determined by the method of Bradford (Bio-Rad protein assay, microplate standard assay). The lysate was adjusted to 2 mg/ml. | |
| 50 μg | |
| Human | |
| Almacenar a -80°C. Dividir para evitar repetir la congelación y descongelación. |
| Breast Duct | |
| Buffer A: 10mM HEPES pH 7.9, 1.5mM MgCl2, 10mM KCl, 0.5 mM DTT. Buffer C: 20mM HEPES pH 7.9, 25%(v/v) Glycerol , 0.42M NaCl , 1.5mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT & 0.5 mM PMSF. Buffer D : 20mM HEPES pH 7.9, 20%(v/v) glycerol, 50mM KCl, 0.2 mM EDTA, 0.5 mM DTT & 0.5 mM PMSF. | |
| 12.5% SDS-PAGE Stained with Coomassie Blue. | |
| In Buffer D. | |
| 2.5 mg/mL |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido